Alpha Q Advisors LLC Bristol Myers Squibb CO Transaction History

Alpha Q Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 29, 2024	SELL	$48.48 - $57.85 $18,616 - $22,214	-384 Reduced 6.56%	5,473 $281 Million
Q3 2023 Oct 27, 2023	SELL	$57.89 - $64.73 $41,101 - $45,958	-710 Reduced 10.81%	5,857 $340 Million
Q2 2023 Aug 08, 2023	BUY	$63.71 - $70.74 $66,831 - $74,206	1,049 Added 19.01%	6,567 $420 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $73,858 - $83,771	-1,124 Reduced 16.92%	5,518 $382 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $454,844 - $538,599	6,642 New	6,642 $478 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Alpha Q Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Q Advisors LLC with notifications on news.